NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Languages English Remove constraint Languages: English Genre Technical Report Remove constraint Genre: Technical Report Copyright Public domain Remove constraint Copyright: Public domain

Search Results

201. Evaluation and reporting of age-, race-, and ethnicity-specific data in medical device clinical studies: guidance for Industry and Food and Drug Administration staff

202. Establishing the performance characteristics of in vitro diagnostic devices for the detection or detection and differentiation of human papillomaviruses: guidance for Industry and Food and Drug Administration staff

203. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 1(R1) : residue on ignition/sulphated ash general chapter

204. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 2(R1) : test for extractable volume of parenteral preparations general chapter

205. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 3(R1) : test for particulate contamination : subvisible particles general chapter

206. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 4A(R1) : microbiological examination of nonsterile products : microbial enumeration tests general chapter

207. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 4B(R1) : microbiological examination of nonsterile products : tests for specified microorganisms general chapter

208. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 4C(R1) : microbiological examination of nonsterile products : acceptance criteria for pharmaceutical preparations and substances for pharmaceutical use general chapter

209. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 5(R1) : disintegration test general chapter

210. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 9(R1) : tablet friability general chapter

211. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 10(R1) : polyacrylamide gel electrophoresis general chapter

212. Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to Congressional requesters

213. Workplace safety and health: information on OSHA training for workers on workplace hazards : report to the Chairman, Subcommittee on Health, Employment, Labor, and Pensions, Committee on Education and the Workforce, House of Representatives

214. Health information technology: HHS should assess the effectiveness of its efforts to enhance patient access to and use of electronic health information : report to Congressional requesters

215. Antibiotic resistance: more information needed to oversee use of medically important drugs in food animals : report to Congressional requesters

216. VA disability benefits: additional planning would enhance efforts to improve the timeliness of appeals decisions : report to Congressional addressees

217. Medicare provider education: oversight of efforts to reduce improper billing needs improvement : report to the Chairman, Committee on Finance, U.S. Senate

218. Medicaid program integrity: CMS should build on current oversight efforts by further enhancing collaboration with states : report to the Chairman, Committee on Finance, U.S. Senate

219. Pediatric trauma centers: availability, outcomes, and federal support related to pediatric trauma care : report to Congressional requesters

220. Veterans' health care: preliminary observations on veterans' access to choice program care : testimony before the Committee on Veterans' Affairs, House of Representatives

221. Veterans' health care: limited progress made to address concerns that led to high-risk designation : testimony before the Committee on Veterans' Affairs, U.S. Senate

222. Veterans health administration: actions needed to better recruit and retain clinical and administrative staff : testimony before the Subcommittee on Health, Committee on Veterans' Affairs, House of Representatives

223. Health care: telehealth and remote patient monitoring use in Medicare and selected federal programs : report to Congressional committees

224. Medicaid demonstrations: federal action needed to improve oversight of spending : report to the Chairman, Committee on Finance, U.S. Senate

225. Medicare advantage: CMS should use data on disenrollment and beneficiary health status to strengthen oversight : report to Congressional Requesters

226. Veterans crisis line: further efforts needed to improve service : statement for the record for the Committee on Veterans' Affairs, House of Representatives

227. Medicaid personal care services: more harmonized program requirements and better data are needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

228. Emerging infectious diseases: actions needed to ensure improved response to Zika virus disease outbreaks : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

229. Veterans Affairs: improper payment estimates and ongoing efforts for reduction : testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives

230. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 8 (R1) : sterility test general chapter

231. Preliminary analysis of legislation that would replace subsidies for health care with block grants

243. Second partial report on Project no. 37 -- study of errors in field artillery practice: subject: an analysis of the sources of error in the use of the panoramic telescope M12 and development of principles of design for an improved instrument

250. Rebalancing long-term care: the role of the Medicaid HCBS waiver program